



@article {3257,
	title = {Magnetic Bioinspired Hybrid Nanostructured Collagen-Hydroxyapatite Scaffolds Supporting Cell Proliferation and Tuning Regenerative Process},
	journal = {Acs Applied Materials \& Interfaces},
	volume = {6},
	year = {2014},
	month = {2014},
	pages = {15697-15707},
	url = {<Go to ISI>://WOS:000342328300010},
	author = {Tampieri, Anna and Iafisco, Michele and Sandri, Monica and Panseri, Silvia and Cunha, Carla and Sprio, Simone and Savini, Elisa and Uhlarz, Marc and Herrmannsdoerfer, Thomas}
}
@article {2879,
	title = {E-cadherin and adherens-junctions stability in gastric carcinoma: Functional implications of glycosyltransferases involving N-glycan branching biosynthesis, N-acetylglucosaminyltransferases III and v},
	journal = {Biochimica et Biophysica Acta - General Subjects},
	volume = {1830},
	year = {2013},
	note = {Cited By (since 1996):1Export Date: 12 December 2013Source: Scopus},
	month = {2013///},
	pages = {2690 - 2700},
	url = {http://www.scopus.com/inward/record.url?eid=2-s2.0-84873589547\&partnerID=40\&md5=ea238ee2045a2bbfb910b24526aac863},
	author = {Pinho, S.S. and Figueiredo, J. and Cabral, J. and Carvalho, S. and Dourado, J. and Magalh{\~a}es, A. and G{\"a}rtner, F. and Mendon{\c c}a, A.M. and Isaji, T. and Gu, J. and Carneiro, F. and Seruca, R. and Taniguchi, N. and Reis, C.A.}
}
@article {2234,
	title = {Bone marrow-derived endothelial progenitors expressing delta-like 4 (Dll4) regulate tumor angiogenesis},
	journal = {PLoS ONEPLoS ONE},
	volume = {6},
	year = {2011},
	note = {Cited By (since 1996): 8Export Date: 21 November 2012Source: ScopusArt. No.: e18323doi: 10.1371/journal.pone.0018323Language of Original Document: EnglishCorrespondence Address: Dias, S.; Angiogenesis Laboratory, CIPM/Portuguese Institute of Oncology, Lisbon, Portugal; email: sergidias@ipolisboa.min-saude.ptChemicals/CAS: fibronectin, 86088-83-7; vasculotropin, 127464-60-2; DLL4 protein, mouse; Intracellular Signaling Peptides and Proteins; Membrane ProteinsReferences: Asahara, T., Masuda, H., Takahashi, T., Kalka, C., Pastore, C., Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization (1999) Circ Res, 85, pp. 221-228;Rafii, S., Lyden, D., Benezra, R., Hattori, K., Heissig, B., Vascular and haematopoietic stem cells: Novel targets for anti-angiogenesis therapy? (2002) Nat Rev Cancer, 2, pp. 826-835. , Review; 
Lyden, D., Hattori, K., Dias, S., Costa, C., Blaikie, P., Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth (2001) Nat Med, 7, pp. 1194-1201; 
Larrivee, B., Niessen, K., Pollet, I., Corbel, S.Y., Long, M., Minimal contribution of marrow-derived endothelial precursors to tumor vasculature (2005) J Immunol, 175, pp. 2890-2899; 
Peters, B.A., Diaz, L.A., Polyak, K., Meszler, L., Romans, K., Contribution of bone marrow-derived endothelial cells to human tumor vasculature (2005) Nat Med, 11, pp. 261-262; 
Pasquier, E., Dias, S., Endothelial progenitor cells: Hope beyond controversy (2010) Curr Cancer Drug Targets, 10 (8), pp. 914-921; 
Dudley, A.C., Udagawa, T., Melero-Martin, J.M., Shih, S.C., Curatolo, A., Bone marrow is a reservoir for proangiogenic myelomonocytic cells but not endothelial cells in spontaneous tumors (2010) Blood, 116 (17), pp. 2267-2271; 
Krebs, L.T., Xue, Y., Norton, C.R., Shutter, J.R., Maguire, M., Notch signaling is essential for vascular morphogenesis in mice (2000) Genes Dev, 14, pp. 1343-1352; 
Uyttendaele, H., Ho, J., Rossant, J., Kitajewski, J., Vascular patterning defects associated with expression of activated Notch4 in embryonic endothelium (2001) Proc Natl Acad Sci U S A, 98, pp. 5643-5648; 
Duarte, A., Hirashima, M., Benedito, R., Trindade, A., Diniz, P., Dosage-sensitive requirement for mouse Dll4 in artery development (2004) Genes Dev, 18, pp. 2474-2478; 
Gale, N.W., Dominguez, M.G., Noguera, I., Pan, L., Hughes, V., Haploinsufficiency of delta-like 4 ligand results in embryonic lethality due to major defects in arterial and vascular development (2004) Proc Natl Acad Sci U S A, 101, pp. 15949-15954; 
Carmeliet, P., Ferreira, V., Breier, G., Pollefeyt, S., Kieckens, L., Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele (1996) Nature, 380, pp. 435-439; 
Mailhos, C., Modlich, U., Lewis, J., Harris, A., Bicknell, R., Delta4, an endothelial specific notch ligand expressed at sites of physiological and tumor angiogenesis (2001) Differentiation, 69, pp. 135-144; 
Oliner, J., Min, H., Leal, J., Yu, D., Rao, S., Suppression of angiogenesis and tumor growth by selective inhibition of angiopoietin-2 (2004) Cancer Cell, 6, pp. 507-516; 
Patel, N.S., Li, J.L., Generali, D., Poulsom, R., Cranston, D.W., Up-regulation of delta-like 4 ligand in human tumor vasculature and the role of basal expression in endothelial cell function (2005) Cancer Res, 65, pp. 8690-8697; 
Williams, C.K., Li, J.L., Murga, M., Harris, A.L., Tosato, G., Up-regulation of the Notch ligand Delta-like 4 inhibits VEGF-induced endothelial cell function (2006) Blood, 107, pp. 931-939; 
Caiado, F., Real, C., Carvalho, T., Dias, S., Notch pathway modulation on bone marrow-derived vascular precursor cells regulates their angiogenic and wound healing potential (2008) PLoS One, 3, pp. e3752; 
Escudier, B., Eisen, T., Stadler, W.M., Szczylik, C., Oudard, S., Sorafenib in advanced clear-cell renal-cell carcinoma (2007) N Engl J Med, 356, pp. 125-134; 
Llovet, J.M., Ricci, S., Mazzaferro, V., Hilgard, P., Gane, E., Sorafenib in advanced hepatocellular carcinoma (2008) N Engl J Med, 359, pp. 378-390; 
Motzer, R.J., Bukowski, R.M., Targeted therapy for metastatic renal cell carcinoma (2006) J Clin Oncol, 24, pp. 5601-5608; 
Bergers, G., Hanahan, D., Modes of resistance to anti-angiogenic therapy (2008) Nat Rev Cancer, 8, pp. 592-603; 
Verheul, H.M., Pinedo, H.M., Possible molecular mechanisms involved in the toxicity of angiogenesis inhibition (2007) Nat Rev Cancer, 7, pp. 475-485; 
Noguera-Troise, I., Daly, C., Papadopoulos, N.J., Coetzee, S., Boland, P., Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis (2006) Nature, 444, pp. 1032-1037; 
Ridgway, J., Zhang, G., Wu, Y., Stawicki, S., Liang, W.C., Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis (2006) Nature, 444, pp. 1083-1087; 
Moore, M.A., Hattori, K., Heissig, B., Shieh, J.H., Dias, S., Mobilization of endothelial and hematopoietic stem and progenitor cells by adenovector-mediated elevation of serum levels of SDF-1, VEGF, and angiopoietin-1 (2001) Ann N Y Acad Sci, 938, pp. 36-45. , discussion 45-37; 
Yamaguchi, J., Kusano, K.F., Masuo, O., Kawamoto, A., Silver, M., Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization (2003) Circulation, 107, pp. 1322-1328; 
Leslie, J.D., Ariza-McNaughton, L., Bermange, A.L., McAdow, R., Johnson, S.L., Endothelial signalling by the Notch ligand Delta-like 4 restricts angiogenesis (2007) Development, 134, pp. 839-844; 
Trindade, A., Kumar, S.R., Scehnet, J.S., Lopes-da-Costa, L., Becker, J., Overexpression of delta-like 4 induces arterialization and attenuates vessel formation in developing mouse embryos (2008) Blood, 112, pp. 1720-1729; 
Huang, M.T., Mason, J.C., Birdsey, G.M., Amsellem, V., Gerwin, N., Endothelial intercellular adhesion molecule (ICAM)-2 regulates angiogenesis (2005) Blood, 106, pp. 1636-1643; 
Deutsch, U., Schlaeger, T.M., Dehouck, B., Doring, A., Tauber, S., Inducible endothelial cell-specific gene expression in transgenic mouse embryos and adult mice (2008) Exp Cell Res, 314, pp. 1202-1216; 
Dias, S., Thomas, H., Balkwill, F., Multiple molecular and cellular changes associated with tumour stasis and regression during IL-12 therapy of a murine breast cancer model (1998) Int J Cancer, 75 (1), pp. 151-157; 
Scott, K.A., Holdsworth, H., Balkwill, F.R., Dias, S., Exploiting changes in the tumour microenvironment with sequential cytokine and matrix metalloprotease inhibitor treatment in a murine breast cancer model (2000) Br J Cancer, 83 (11), pp. 1538-1543
},
	month = {2011///},
	abstract = {Neo-blood vessel growth (angiogenesis), which may involve the activation of pre-existing endothelial cells (EC) and/or the recruitment of bone marrow-derived vascular precursor cells (BM-VPC), is essential for tumor growth. Molecularly, besides the well established roles for Vascular endothelial growth factor (VEGF), recent findings show the Notch signalling pathway, in particular the ligand Delta-like 4 (Dll4), is also essential for adequate tumor angiogenesis; Dll4 inhibition results in impaired, non-functional, angiogenesis and reduced tumor growth. However, the role of BM-VPC in the setting of Notch pathway modulation was not addressed and is the subject of the present report. Here we show that SDF-1 and VEGF, which are produced by tumors, increase Dll4 expression on recruited BM-VPC. Mechanistically, BM-VPC activated, in a Dll4-dependent manner, a transcriptional program on mature EC suggestive of EC activation and stabilization. BM-VPC induced ICAM-2 and Fibronectin expression on EC, an effect that was blocked by a Dll4-specific neutralizing antibody. In vivo, transplantation of BM-VPC with decreased Dll4 into tumor-bearing mice resulted in the formation of microvessels with decreased pericyte coverage and reduced fibronectin expression. Consequently, transplantation of BM-VPC with decreased Dll4 resulted in impaired tumor angiogenesis, increased tumor hypoxia and apoptosis, and decreased tumor growth. Taken together, our data suggests that Dll4 expression by BM-VPC affects their communication with tumor vessel endothelial cells, thereby modulating tumor angiogenesis by affecting vascular stability. {\textcopyright} 2011 Real et al.},
	keywords = {angiogenesis, animal, animal cell, animal tissue, Animals, apoptosis, article, blood vessel, Blood Vessels, bone marrow, bone marrow cell, Bone Marrow Cells, cell activation, Cell Line, Tumor, cell proliferation, controlled study, cytology, delta like 4 protein, DLL4 protein, mouse, Endothelial Cells, endothelium cell, Female, Fibronectin, gene expression, gene expression regulation, genetics, human, human cell, Humans, hypoxia, in vitro study, in vivo study, intercellular adhesion molecule 2, Intracellular Signaling Peptides and Proteins, membrane protein, Membrane Proteins, metabolism, Mice, mouse, Mus, neoplasm, Neoplasms, neovascularization (pathology), Neovascularization, Pathologic, neutralizing antibody, nonhuman, Notch receptor, Pathology, pericyte, protein expression, signal peptide, solid tumor, stem cell, stem cell transplantation, Stem cells, stromal cell derived factor 1, tumor cell line, tumor growth, unclassified drug, vascularization, vasculotropin},
	isbn = {19326203 (ISSN)},
	url = {http://www.scopus.com/inward/record.url?eid=2-s2.0-79953685607\&partnerID=40\&md5=60a33b7d91c1502050bc560303255881},
	author = {Real, C. and Rem{\'e}dio, L. and Caiado, F. and Igreja, C. and Borges, C. and Trindade, A. and Pinto-Do-{\'O}, P. and Yagita, H. and Duarte, A. and Dias, S.}
}
@article {2285,
	title = {TNF-α regulates the effects of irradiation in the mouse bone marrow microenvironment},
	journal = {PLoS ONEPLoS ONE},
	volume = {5},
	year = {2010},
	note = {Cited By (since 1996): 3Export Date: 21 November 2012Source: ScopusArt. No.: e8980doi: 10.1371/journal.pone.0008980Language of Original Document: EnglishCorrespondence Address: Cacha{\c c}o, A. S.; Angiogenesis Laboratory, Centro de Investiga{\c c}{\~a}o em Patobiologia Molecular (CIPM), Instituto Portugues de Oncologia de Francisco Gentil, Lisboa, PortugalChemicals/CAS: vasculotropin, 127464-60-2; vasculotropin A, 489395-96-2; Antibodies, Neutralizing; Matrix Metalloproteinases, 3.4.24.-; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor AReferences: Baud, V., Karin, M., Signal transduction by tumor necrosis factor and its relatives (2001) Trends Cell Biol, 11, pp. 372-377;Balkwill, F., Mantovani, A., Inflammation and cancer: Back to Virchow? (2001) Lancet, 357, pp. 539-345; 
Lejeune, F.J., R{\"u}egg, C., Recombinant human tumor necrosis factor: An efficient agent for cancer treatment (2006) Bull Cancer, 93 (8), pp. E90-100; 
Moore, R.J., Owens, D.M., Stamp, G., Arnott, C., Burke, F., Mice deficient in tumor necrosis factor-alpha are resistant to skin carcinogenesis (1999) Nat Med, 5, pp. 828-831; 
Scott, K.A., Arnott, C.H., Robinson, S.C., Moore, R.J., Thompson, R.G., TNF-alpha regulates epithelial expression of MMP-9 and integrin alphavbeta6 during tumour promotion. A role for TNF-alpha in keratocyte migration? (2004) Oncogene, 23, pp. 6954-6966; 
Hagemann, T., Robinson, S.C., Schulz, M., Trumper, L., Balkwill, F.R., Enhanced invasiveness of breast cancer cell lines upon co-cultivation with macrophages is due to TNF-alpha dependent up-regulation of matrix metalloproteases (2004) Carcinogenesis, 25 (8), pp. 1543-1549; 
Yang, W.L., Godwin, A.K., Xu, X.X., Tumor necrosis factor-alpha-induced matrix proteolytic enzyme production and basement membrane remodeling by human ovarian surface epithelial cells: Molecular basis linking ovulation and cancer risk (2004) Cancer Res, 64 (4), pp. 1534-1540; 
Redondo-Mu{\~n}oz, J., Escobar-D{\'\i}az, E., Samaniego, R., Terol, M.J., Garc{\'\i}a-Marco, J.A., MMP-9 in B-cell chronic lymphocytic leukemia is up-regulated by alpha4beta1 integrin or CXCR4 engagement via distinct signaling pathways, localizes to podosomes, and is involved in cell invasion and migration (2006) Blood, 108 (9), pp. 3143-3151; 
Rosselli, F., Sancean, J., Gluckman, E., Abnormal lymphokine production: A novel feature of the genetic disease Fanconi anemia. In vitro and in vivo spontaneous overproduction of tumor necrosis factor α (1994) Blood, 83 (5), pp. 1216-1225; 
Dufour, C., Corcione, A., Svahn, J., Haupt, R., Poggi, V., TNF-alpha and IFN-gamma are overexpressed in the bone marrow of Fanconi anemia patients and TNF-alpha suppresses erythropoiesis in vitro (2003) Blood, 102 (6), pp. 2053-2059; 
Kuruvilla J, Leitch HA, Vickars LM, Galbraith PF, Li CH, et al. (2003) Aplastic anemia following administration of a tumor necrosis factor-alpha inhibitor. Eur J Haematol 71(5): 396-8. Erratum in: Eur J Haematol. (2004) 72(4):306Hara, T., Ando, K., Tsurumi, H., Moriwaki, H., Excessive production of tumor necrosis factor-alpha by bone marrow T lymphocytes is essential in causing bone marrow failure in patients with aplastic anemia (2004) Eur J Haematol, 73 (1), pp. 10-16; 
Kerbauy, D.B., Deeg, H.J., Apoptosis and antiapoptotic mechanisms in the progression of myelodysplastic syndromes (2007) Exp Hematol, 35 (11), pp. 1739-1746; 
Lv, L., Kerzic, P., Lin, G., Schnatter, A.R., Bao, L., The TNF-alpha 238A polymorphism is associated with susceptibility to persistent bone marrow dysplasia following chronic exposure to benzene (2007) Leuk Res, 31 (11), pp. 1479-1485; 
Boula, A., Voulgarelis, M., Giannouli, S., Katrinakis, G., Psyllaki, M., Effect of cA2 anti.tumor necrosis factor-alpha antibody therapy on hematopoiesis of patients with myelodysplastic syndromes (2006) Clin Cancer Res, 12, pp. 3099-3108; 
Deeg, H.J., Gotlib, J., Beckham, C., Dugan, K., Holmberg, L., Soluble TNF receptor fusion protein (etanercept) for the treatment of myelodysplastic syndrome: A pilot study (2002) Leukemia, 16 (2), pp. 162-164; 
Maciejewski JP, Risitano AM, Sloand EM, Wisch L, Geller N, et al. (2002) Br J Haematol 117(1): 119-26. Erratum in: Br J Haematol (2002) 117(4):1002. Ristiano Antonio M [corrected to Risitano Antonio M]De Roos, A.J., Deeg, H.J., Davis, S., A population-based study of survival in patients with secondary myelodysplastic syndromes (MDS): Impact of type and treatment of primary cancers (2007) Cancer Causes Control, 18 (10), pp. 1199-1208; 
Malcovati, L., Nimer, S.D., Myelodysplastic syndromes: Diagnosis and Staging (2008) Cancer Control, 15 (4 SUPPL.EMENT), pp. 4-13; 
Haran-Ghera, N., Peled, A., Krautghamer, R., Resnitzky, P., Initiation and promotion in radiation-induced myeloid leukemia (1992) Leukemia, 6 (7), pp. 689-695; 
Padmanabhan, A., Baker, J.A., Zirpoli, G., Sait, S.N., Ford, L.A., Acute myeloid leukemia and myelodysplastic syndrome following breast cancer: Increased frequency of other cancers and of cancers in multiple family members (2008) Leuk Res, 32 (12), pp. 1820-1823; 
Zhang, Y., Harada, A., Bluethmann, H., Wang, J.B., Nakao, S., Tumor necrosis factor (TNF) is a physiologic regulator of hematopoietic progenitor cells: Increase of early hematopoietic progenitor cells in TNF receptor p55-deficient mice in vivo and potent inhibition of progenitor cell proliferation by TNF alpha in vitro (1995) Blood, 86 (8), pp. 2930-2937; 
Rebel, V.I., Hartnett, S., Hill, G.R., Lazo-Kallanian, S.B., Ferrara, J.L., Essential role for the p55 tumor necrosis factor receptor in regulating hematopoiesis at a stem cell level (1999) J Exp Med, 190 (10), pp. 1493-1504; 
Drutskaya, M.S., Ortiz, M., Liepinsh, D.J., Kuprash, D.V., Nedospasov, S.A., Inhibitory effects of tumor necrosis factor on hematopoiesis seen in vitro are translated to increased numbers of both committed and multipotent progenitors in TNF-deficient mice (2005) Exp Hematol, 33 (11), pp. 1348-1356; 
R{\"u}be, C.E., Wilfert, F., Uthe, D., Schmid, K.W., Knoop, R., Modulation of radiation-induced tumour necrosis factor alpha (TNF-alpha) expression in the lung tissue by pentoxifylline (2002) Radiother Oncol, 64 (2), pp. 177-187; 
Zhang, M., Qian, J., Xing, X., Kong, F.M., Zhao, L., Inhibition of the tumor necrosis factor-alpha pathway is radioprotective for the lung (2008) Clin Cancer Res, 14 (6), pp. 1868-1876; 
Daigle, J.L., Hong, J.H., Chiang, C.S., McBride, W.H., The role of tumor necrosis factor signaling pathways in the response of murine brain to irradiation (2001) Cancer Res, 61 (24), pp. 8859-8865; 
Dy, L.C., Pei, Y., Travers, J.B., Augmentation of ultraviolet B radiation-induced tumor necrosis factor production by the epidermal platelet-activating factor receptor (1999) J Biol Chem, 274 (38), pp. 26917-26921; 
M{\"u}ller, K., Meineke, V., Radiation-induced alterations in cytokine production by skin cells (2007) Exp Hematol, 35 (4 SUPPL. 1), pp. 96-104; 
Tolle, D.V., Seed, T.M., Fritz, T.E., Lombard, L.S., Poole, C.M., Acute monocytic leukemia in an irradiated Beagle (1979) Vet Pathol, 16 (2), pp. 243-254; 
Seed, T.M., Chubb, G.T., Tolle, D.V., Sequential changes in bone marrow architecture during continuous low dose gamma irradiation (1981) Scan Electron Microsc, 4, pp. 61-72; 
Sato, H., Seiki, M., Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells (1993) Oncogene, 8, pp. 395-405; 
Wielockx, B., Lannoy, K., Shapiro, S.D., Inhibition of matrix metalloproteinases blocks lethal hepatitis and apoptosis induced by tumor necrosis factor and allows safe antitumor therapy (2001) Nat Med, 7, pp. 1202-1208; 
Heissig B, Hattori K, Dias S, Friedrich M, Ferris B, et al. (2002) Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell 31:109(5): 625-37.35Natoli G, Costanzo A, Guido F, Moretti F, Bernardo A, et al. (1998) Nuclear factor kB-independent cytoprotective pathways originating at tumor necrosis factor receptor-associated factor 2. J Biol Chem 273(47): 31262-72.36Barkett, M., Gilmore, T.D., Control of apoptosis by Rel/NF-kappaB transcription factors (1999) Oncogene, 18 (49), pp. 6910-6924; 
Priestley, G.V., Scott, L.M., Ulyanova, T., Papayannopoulou, T., Lack of a4 integrin expression in stem cells restricts competitive function and self-renewal activity (2006) Blood, 107, pp. 2959-2967; 
Walkley, C.R., Shea, J.M., Sims, N.A., Purton, L.E., Orkin, S.H., Rb regulates interactions between hematopoietic stem cells and their bone marrow microenvironment (2007) Cell, 129 (6), pp. 1081-1095. , A; 
Walkley, C.R., Olsen, G.H., Dworkin, S., Fabb, S.A., Swann, J., A microenvironment-induced myeloproliferative syndrome caused by retinoic acid receptor gamma deficiency (2007) Cell, 129 (6), pp. 1097-1110. , B; 
Leone, G., Pagano, L., Ben-Yehuda, D., Voso, M.T., Therapy-related leukemia and myelodysplasia: Susceptibility and incidence (2007) Haematologica, 92 (10), pp. 1389-1398; 
Reza, S., Shetty, V., Dar, S., Qawi, H., Raza, A., Tumor necrosis factor-α levels decrease with anticytokine therapy in patients with myelodysplastic syndromes (1998) J Interferon Cytokine Res, 18 (10), pp. 871-877; 
Raza, A., Qawi, H., Lisak, L., Andric, T., Dar, S., Patients with myelodysplastic syndromes benefit from palliative therapy with amifostine, pentoxifylline, and ciprofloxacin with or without dexamethasone (2000) Blood, 95 (5), pp. 1580-1587
},
	month = {2010///},
	abstract = {Background: Secondary bone marrow (BM) myelodysplastic syndromes (MDS) are increasingly common, as a result of radio or chemotherapy administered to a majority of cancer patients. Patients with secondary MDS have increased BM cell apoptosis, which results in BM dysfunction (cytopenias), and an increased risk of developing fatal acute leukemias. In the present study we asked whether TNF-α, known to regulate cell apoptosis, could modulate the onset of secondary MDS. Principal Findings:We show that TNF-α is induced by irradiation and regulates BM cells apoptosis in vitro and in vivo. In contrast to irradiated wild type (WT) mice, TNF-α deficient (TNF-α KO) mice or WT mice treated with a TNF-α-neutralizing antibody were partially protected from the apoptotic effects of irradiation. Next we established a 3-cycle irradiation protocol, in which mice were sub-lethally irradiated once monthly over a 3 month period. In this model, irradiated WT mice presented loss of microsatellite markers on BM cells, low white blood cell (WBC) counts, reduced megakaryocyte (MK) and platelet levels (thrombocytopenia) and macrocytic anemia, phenoypes that suggest the irradiation protocol resulted in BM dysfunction with clinical features of MDS. In contrast, TNF-α KO mice were protected from the irradiation effects: BM cell apoptosis following irradiation was significantly reduced, concomitant with sustained BM MK numbers and absence of other cytopenias. Moreover, irradiated WT mice with long term (>=5 months) BM dysfunction had increased BM angiogenesis, MMPs and VEGF and NFkB p65, suggestive of disease progression. Conclusion:Taken together, our data shows that TNF-α induction following irradiation modulates BM cell apoptosis and is a crucial event in BM dysfunction, secondary MDS onset and progression. {\textcopyright} 2010 Cacha{\c c}o et al.},
	keywords = {angiogenesis, animal, animal cell, animal experiment, animal model, animal tissue, Animals, Antibodies, Neutralizing, apoptosis, article, Blood, blood cell count, Blotting, Western, bone marrow, bone marrow cell, Bone Marrow Cells, C57BL mouse, Cell Line, clinical feature, controlled study, cytokine production, disease course, drug effect, Enzyme Activation, flow cytometry, genetics, immunology, in vitro study, in vivo study, irradiation, leukocyte, leukocyte count, Leukocytes, macrocytic anemia, male, matrix metalloproteinase, Matrix Metalloproteinases, megakaryocyte, Megakaryocytes, metabolism, Mice, Mice, Inbred C57BL, Mice, Knockout, microenvironment, microsatellite marker, mouse, mouse mutant, Mus, myelodysplastic syndrome, neovascularization (pathology), Neovascularization, Pathologic, neutralizing antibody, nonhuman, Pathology, phenotype, protein expression, radiation dose, radiation exposure, Reverse Transcriptase Polymerase Chain Reaction, reverse transcription polymerase chain reaction, thrombocytopenia, transcription factor RelA, tumor necrosis factor alpha, tumor necrosis factor alpha antibody, Tumor Necrosis Factor-alpha, Vascular Endothelial Growth Factor A, vascularization, vasculotropin, vasculotropin A, Western blotting, zymography},
	isbn = {19326203 (ISSN)},
	url = {http://www.scopus.com/inward/record.url?eid=2-s2.0-77749280454\&partnerID=40\&md5=741f4070ed47c15899f89c6d21b4e8f8},
	author = {Cacha{\c c}o, A.S. and Carvalho, T. and Santos, A.C. and Igreja, C. and Fragoso, R. and Rio, C.O. and Ferreira, M. and Serpa, J. and Correia, S. and Pinto-Do-{\'O}, P. and Dias, S.}
}
@book {2478,
	title = {Bonelike{\textregistered}/PLGA hybrid materials for bone regeneration: In vivo evaluation},
	series = {Materials Science ForumMater Sci Forum},
	volume = {455-456},
	year = {2004},
	note = {Conference code: 63332Cited By (since 1996): 1Export Date: 21 November 2012Source: ScopusCODEN: MSFOELanguage of Original Document: EnglishCorrespondence Address: Oliveira, J.M.; Inst. de Engenharia Biom{\'e}dica, Lab. de Biomateriais, Rua do Campo Alegre, 823, 4150-180 Porto, Portugal; email: jmolive@fe.up.ptReferences: Praemer, A., Furner, S., Rice, D.P., (1992) Am. Acad. Orthop. Surg., p. 1;Glowacki, J., Mulliken, J.B., (1985) Clin. Plast. Surg., 12, p. 233; 
Buck, B.E., Malinin, T.I., Brown, M.D., (1989) Clin. Orthop., 36, p. 129; 
Sepulveda, P., Bressiani, A.H., Bressiani, J.C., Mesenguer, L., K{\"o}nig Jr., B., (2002) J. Biomed. Mater. Res. Vol., 62, p. 587; 
Glimcher, M.J., (1987) Instr. Course Lect., 36, p. 46; 
Yakamuro, T., Hench, L.L., Wilson, J., (1990) CRC Handbook of Bioactive Ceramics, 2, pp. 245-252; 
Klemm, K.W., (1993) Clin. Orthop. \& Rel. Res., 295, pp. 63-76; 
Agrawal, C.M., Ray, R.B., (2001) J. Biomed. Mater. Res., 55, p. 141; 
Santos, J.D., Campbell, J.K., Winton, G.H., (2000), European Patent N{\textdegree} W00068164Lopes, M.A., Santos, J.D., Monteiro, F.J., Ohtsuki, C., Osaka, A., Kaneko, S., Inoue, H., (2001) J. Biomed. Mater. Res., 54, p. 463
},
	month = {2004///},
	pages = {374 - 377},
	address = {Caparica},
	abstract = {The biocompatibility and osteoconductive potential of Bonelike{\textregistered} and Bonelike{\textregistered}/PLGA hybrid materials were evaluated through subcutaneous and tibiae implantations for a 4 week period. Qualitative histology was performed to evaluate new bone formation and characterise bone-implant interface and results showed that Bonelike{\textregistered}/PLGA hybrid materials promote extensive bone growth. After the 4 week implantation period, Bonelike{\textregistered} resorption was recognized, which may be due to the presence of resorbable β and α-tricalcium phosphate phases.},
	keywords = {Bacteria, Biodegradation, Bone, Bonelike resorption, Bonelike{\textregistered}, Histological studies, histology, Hybrid materials, hydroxyapatite, In vivo, physiology, PLGA, Polymers, Surgery, Tissue},
	isbn = {02555476 (ISSN)},
	url = {http://www.scopus.com/inward/record.url?eid=2-s2.0-17044449739\&partnerID=40\&md5=4d9e5103b703ff0f016854e278f75823},
	author = {Oliveira, J.M. and Kawai, T. and Lopes, M.A. and Ohtsuki, C. and Santos, J.D. and Afonso, A.},
	editor = {Martins R. and Fortunato E. and Ferreira I. and Dias C.}
}
@book {2479,
	title = {Influence of characteristics of the starting hydroxyapatite powders and of deagglomeration procedure, on rheological behaviour of HA suspensions},
	series = {Materials Science ForumMater Sci Forum},
	volume = {455-456},
	year = {2004},
	note = {Conference code: 63332Cited By (since 1996): 5Export Date: 21 November 2012Source: ScopusCODEN: MSFOELanguage of Original Document: EnglishCorrespondence Address: Ferreira, J.M.F.; Dept. of Ceramics Engineering, CICECO, Univ. of Aveiro, 3810-193 Aveiro, Portugal; email: jmf@cv.ua.ptReferences: Kanazawa, T., (1989) Inorganic Phosphate Materials, 52, p. 15. , Materials Science Monographs, (Elsevier Science Publishers, Amsterdam);Elliot, J.C., (1994) Structure and Chemistry of the Apatites and Other Calcium Orthophosphates. Studies in Organic Chemistry, 18. , Elsevier Science, Netherlands; 
Ohgushi, H., Okumura, M., Yoshikawa, T., Inoue, K., Senpuku, N., Tamai, S., Shors, E.C., (1992) J. Biomed. Mater. Res., 26, p. 885; 
Saggio-Woyanski, J., Scott, C., (1992) Am. Ceram. Soc. Bull., 71, p. 1674; 
Lyckfeldt, O., Ferreira, J.M.F., (1998) J. Eur. Ceram. Soc., 18, p. 131; 
Lorenzo, L.M.R., (1999), PhD Thesis MadridOlhero, S.M., Ferreira, J.M.F., (2003) Powder Thecnology, , accepted for publication
},
	month = {2004///},
	pages = {361 - 365},
	address = {Caparica},
	abstract = {In order to evaluate how the characteristics of starting HA powders affect their dispersion ability, several tests were made, including particle size distribution, particle morphology (SEM) and rheological measurements of the suspensions. To enable the preparation of concentrated suspensions as high as possible, the influence of deagglomeration procedure on rheological behaviour of hydroxyapatite aqueous suspensions was evaluated. The results revealed significant differences in the dispersing ability of the powders and on the maximum achievable solids loading. In fact, the maximum solids volume fraction that was possible to incorporate in the initial suspension of HA                        R was only 35-vol.\%, while with the HA
                        S it has been possible to start from 45-vol.\% suspensions. Ball milling revealed to be more efficient than planetary milling in the preparation of HA
                        R suspensions, and enabled to achieve a maximum solids volume fraction of 45-vol.\% at the end of long milling period, which included successive incremental additions of powder. The powder HA
                        S exhibited a much better dispersing ability, enabling the preparation of 60-vol.\% solids only after two hours of planetary milling.
},
	keywords = {Agglomeration, Bioceramics, crystallography, Deagglomeration, Foaming processes, hydroxyapatite, medicine, morphology, Particle size analysis, Powder characteristics, Powders, rheology, Scanning electron microscopy, Sedimentation, Sintering},
	isbn = {02555476 (ISSN)},
	url = {http://www.scopus.com/inward/record.url?eid=2-s2.0-17044460745\&partnerID=40\&md5=5c72052a267f3f7c544667ce61b5e434},
	author = {Lemos, A.F. and Santos, J.D. and Ferreira, J.M.F.},
	editor = {Martins R. and Fortunato E. and Ferreira I. and Dias C.}
}
@book {2477,
	title = {Production of porous hydroxyapatite with potential for controlled drug delivery},
	series = {Materials Science ForumMater Sci Forum},
	volume = {455-456},
	year = {2004},
	note = {Conference code: 63332Cited By (since 1996): 7Export Date: 21 November 2012Source: ScopusCODEN: MSFOELanguage of Original Document: EnglishCorrespondence Address: Queiroz, A.C.; INEB, Inst. de Engenharia Biom{\'e}dica, R do Campo Alegre, 823, 4150-180 Porto, Portugal; email: aqueiroz@ineb.up.ptReferences: Krejci, C.B., Bissada, N.F., Farah, C., Greenwell, H., (1987) J. Periodontology, 58, p. 521;Seymour, R.A., Heasman, P.A., MacGregor, I.D.M., The pathogenesis of periodontal disease (1992) Drugs, Diseases, and the Periodontium, , Oxford University Press; 
(1996) Journal of Periodontology, 67, p. 831; 
Soskolne, W.A., Heasman, H.A., Stabholz, A., Smart, G.J., Palmer, M., Flashner, M., Newman, H.N., (1997) Journal of Periodontology, 68, p. 32; 
Da Silva, M.H.P., Lemos, A.F., Gibson, I.R., Ferreira, J.M.F., Santos, J.D., (2002) J. of Non-crystaline Solids, 304, p. 286; 
Chang, B., Lee, C., Hong, K., Youn, H., Ryu, H., Chung, S., Park, K., (2000) Biomat., 21, p. 1291; 
Ewers, R., Simons, B., (1992) Biomaterials - Hard Tissue Repair and Replacement, , Elsevier Sc; 
Ohgushi, H., Okumura, M., Yoshikawa, T., Inoue, K., Senpuku, N., Tamai, S., Shors, E.C., (1992) Journal of Biomedical Materials Research, 26, p. 885; 
Barinov, S.M., Baschenko, Y.V., (1992) Bioceramics and the Human Body, , Elsevier Sc; 
Hing, K.A., Best, S.M., Tanner, K.E., Bonfield, W., Revell, P.A., (1997) J. Mater. Sc.: Materials in Medicine, 8, p. 731; 
Queiroz, A.C., Teixeira, S., Santos, J.D., Monteiro, F.J., (2003) Bioceramics, , accepted for; 
Santos, J.D., Monteiro, F.J., Gibson, I.R., Knowles, J.C., (2001) Biomaterial, 22, p. 1393
},
	month = {2004///},
	pages = {358 - 360},
	address = {Caparica},
	abstract = {Porous hydroxyapatite was prepared in order to be used as a drug carrier and promote bone ingrowth. For this purpose, the microstructure should have interconnective pores and micro as well as macro porosity, for bone cell adhesion and bone ingrowth. The porous hydroxyapatite prepared by the burn-out method exhibits all these features. For measuring porosity, SEM analysis, mercury intrusion porosimetry and BET were used. FT-IR and XRD analysis revealed that only hydroxyapatite phase was present, being this result similar to the one found for dense samples. The morphology obtained appears to be well adapted to bone growth and drug adsorption.},
	keywords = {Adsorption, Antibiotics, Bioceramics, Controlled drug delivery, Drug Carriers, Drug delivery, Fourier transform infrared spectroscopy, hydroxyapatite, morphology, Polyurethanes, porosity, Porous, Porous materials, Scanning electron microscopy, X ray diffraction analysis},
	isbn = {02555476 (ISSN)},
	url = {http://www.scopus.com/inward/record.url?eid=2-s2.0-17044442244\&partnerID=40\&md5=7baa6f22534360d57deb7862546fb275},
	author = {Queiroz, A.C. and Teixeira, S. and Santos, J.D. and Monteiro, F.J.},
	editor = {Martins R. and Fortunato E. and Ferreira I. and Dias C.}
}
@book {2476,
	title = {Protein adsorption effect on in vitro acellular biodegradation of CaO-P                    2O
                    5 glass ceramics
},
	series = {Materials Science ForumMater Sci Forum},
	volume = {455-456},
	year = {2004},
	note = {Conference code: 63332Cited By (since 1996): 2Export Date: 21 November 2012Source: ScopusCODEN: MSFOELanguage of Original Document: EnglishCorrespondence Address: Santos, J.D.; Inst. de Engenharia Biom{\'e}dica, Laborat{\'o}rio de Biomateriais, Rua do Campo Alegre, 823, 4150-180 Porto, Portugal; email: jdsantos@fe.up.ptReferences: Zeng, Chittur, K.K., Lacefield, W.R., (1999) Biomaterials, 20, p. 377;Ohta, Monna, H., Takahashi, S., (2001) J. Biomed. Mater. Res., 55, p. 409; 
Zyman, Z., Dedukh, N.V., Glusko, V.I., Shcherbyna, S.V., (2002) 17 th European Society for Biomaterials Conference Proceedings, , Barcelona; 
Krajewski, Malavoti, R., Piancatelli, A., (1996) Biomaterials, 17, p. 53; 
El-Ghannam, Ducheyne, P., Shapiro, I.M., (1997) Biomaterials, 18 (4); 
Takami, (1998) J. Biomed. Mater. Res., 40, p. 24; 
Puleo, A., Bizios, R., (1992) J. Biomed. Mater. Res., 26, p. 291; 
Dubois, C., Souchier, C., Couble, M.L., Exbrayat, P., Lissac, M., (1999) Biomat., 20, p. 1841; 
Green, J., Davies, M.C., Roberts, C.J., Tendler, S.J.B., (1997) Biomaterials, 18, p. 405; 
Haynes, C.A., Norde, W., (1994) Colloids and Surfaces B: Biointerfaces, 2, p. 517; 
Dias, G., Lopes, M.A., Gibson, I.R., Santos, J.D., (2002) 17 th Europ. Soc. for Biomat. Conf. Proc., , Barcelona; 
Chun, Na, S.W., Lee, J.H., Chung, J.P., Ryu, I.C., Kim, S.Y., (2002) Key Eng. Mat., 218-220, p. 149
},
	month = {2004///},
	pages = {398 - 401},
	address = {Caparica},
	abstract = {This work reports the in vitro accelular behaviour of a glass ceramic (45P                        2O
                        5-45CaO-5MgO-5K
                        2O), which has significant potential for being used as an alloplastic bone graft. Experiments were carried out by immersing granule samples for a period up to 90 days in Trisbuffer solution at pH 7.4, in the presence and absence of a foetal bovine serum (FBS). The release of calcium, phosphorus, and potassium ions as well as the amount of protein adsorbed was followed by several techniques. The results obtained seem to indicate that the adsorption of proteins on the surface of the material, although causing an initial delay in the degradation, does not hamper the ionic exchange and therefore it is not a barrier for the degradation of the glass ceramic.
},
	keywords = {Adsorption, Bioceramics, Biodegradation, Calcium Compounds, Foetal bovine serum (FBS), Glass ceramics, Hard tissue, Ion exchange, Ionic strength, pH effects, Protein adhesion, Proteins, Tissue},
	isbn = {02555476 (ISSN)},
	url = {http://www.scopus.com/inward/record.url?eid=2-s2.0-3142740181\&partnerID=40\&md5=5452672cf92db3be0d9f232ce3b1a83e},
	author = {Dias, A.G. and Lopes, M.A. and Santos, J.D.},
	editor = {Martins R. and Fortunato E. and Ferreira I. and Dias C.}
}
@article {2545,
	title = {Push-out testing and histological evaluation of glass reinforced hydroxyapatite composites implanted in the tibia of rabbits},
	journal = {Journal of Biomedical Materials ResearchJ. Biomed. Mater. Res.},
	volume = {54},
	year = {2001},
	note = {Cited By (since 1996): 40Export Date: 21 November 2012Source: ScopusCODEN: JBMRBdoi: 10.1002/1097-4636(20010315)54:4<463::AID-JBM10>3.0.CO;2-YPubMed ID: 11426590Language of Original Document: EnglishCorrespondence Address: Santos, J.D.; Laborat{\'o}rio de Biomateriais, INEB, Rua do Campo Alegre, 823, 4150-180 Porto, PortugalChemicals/CAS: Bone Substitutes; Composite Resins; Durapatite, 1306-06-5References: Hyakuna, K., Yamamuro, T., Kotoura, Y., Oka, M., Nakamura, T., Kitsugi, T., Kokubo, T., Kushitani, H., Surface reactions of calcium phosphate ceramics to various solutions (1990) J Biomed Mater Res, 24, pp. 471-488;Klein, C.P.A.T., Driessen, A.A., De Groot, K., Van der Hooff, A., Biodegradation behavior of various calcium phosphate materials in bone tissue (1983) J Biomed Mater Res, 17, pp. 769-784; 
Santos, J.D., Knowles, J.C., Reis, R.L., Monteiro, F.J., Hastings, G.W., Microstructural Characterization of Glass Reinforced Hydroxyapatite Composites (1994) Biomaterials, 15, pp. 5-10; 
Lopes, M.A., Santos, J.D., Monteiro, F.J., Knowles, J.C., Glass Reinforced Hydroxyapatite: A Comprehensive Study of the Effect of Glass Composition on the Crystallography of the Composite (1998) J Biomed Mater Res, 39, pp. 244-251; 
Lopes, M.A., Santos, J.D., Monteiro, F.J., Glass Reinforced Hydroxyapatite Composites: Secondary Phases Proportions and Densification Effects on Biaxial Bending Strength (1999) J Biomed Mater Res, 48, pp. 734-740; 
Lopes, M.A., Saramago, B., Santos, J.D., Monteiro, F.J., Hydrophobicity, Surface Tension and Zeta Potential of Glass Reinforced Hydroxyapatite Composites (1999) J Biomed Mater Res, 45, pp. 370-375; 
Lopes, M.A., Knowles, J.C., Kuru, L., Santos, J.D., Monteiro, F.J., Olsen, I., Flow Cytometry for Assessing Biocompatibility (1998) J Biomed Mater Res, 41, pp. 649-656; 
Kokubo, T., Ito, S., Huang, Z.T., Hayashi, T., Sakka, S., CaP-rich layer formed on high-strength bioactive glass-ceramic A-W (1990) J Biomed Mater Res, 24, pp. 331-343; 
Cho, S.B., Nakanishi, K., Kokubo, T., Soga, N., Ohtsuki, C., Nakamura, T., Kitsugi, T., Yamamuro, T., Dependence of Apatite Formation on Silica Gel on Its Structure: Effect of Heat Treatment (1975) J Am Ceram Soc, 78, pp. 1769-1774; 
Neo, M., Kotani, S., Fujita, Y., Nakamura, T., Yamamuro, T., Bando, Y., Ohtsuki, C., Kokubo, T., Differences in ceramic-bone interface between surface-active ceramics and resorbable ceramics: A study by scanning and transmission electron microscopy (1992) J Biomed Mater Res, 26, pp. 255-267; 
Hamson, K.R., Toth, J.M., Stiehl, J.B., Lynch, K.L., Preliminary experience with a novel model assessing in vivo mechanical strength of bone grafts and substitute materials (1995) Calcif Tissue Int, 57, pp. 64-68; 
Hing, K.A., (1996) Assessment of porous hydroxyapatite for bone replacement, , London: University of London; 
Albrektsson, T., Johansson, C., Quantitative bone tissue reactions to various metallic materials with reference to the so-called osseointegration concept (1991), pp. 357-363. , Davies JE, editor. The bonebiomaterial interface. Toronto: University of Toronto PressProbster, L., Voigh, C.H., Fuhrman, G., Gross, U.M., Tensile and torsional shear strength of the bone implant interface of titanium implants in the rabbit (1994) J Mater Sci: Mater Med, 5, pp. 314-319; 
Kokubo, T., Kushitani, H., Ebisawa, Y., Kitsugi, T., Kotani, S., Oura, K., Yamamuro, T., Apatite formation on bioactive ceramics in body environment (1989), 1, pp. 157-162. , Oonishi H, Aoki H, Sawai K, editors. Bioceramics. Tokyo: Ishiyaku EuroAmerica, IncLeGeros, R.Z., (1991), pp. 4-45. , Meyers HM, editor. Calcium phosphates in oral biology and medicine. New York: KargerOhtsuki, C., Kokubo, T., Neo, M., Kotani, S., Yamamuro, T., Nakamura, T., Bando, Y., Bone-Bonding Mechanism of Sintered β-3CaO-P 2O 5 (1991) Phosphorus Research Bulletin, 1, pp. 191-196; 
Kotani, S., Fujita, Y., Kitsugi, T., Nakamura, T., Yamamuro, T., Ohtsuki, C., Kokubo, T., Bone bonding mechanism of β-tricalcium phosphate (1991) J Biomed Mater Res, 25, pp. 1303-1315; 
Lu, J.X., Gallur, A., Flautre, B., Anselme, K., Descamps, M., Thierry, B., Hardouin, P., Comparative study of tissue reactions to calcium phosphate ceramics among cancellous, cortical, and medullar bone site in rabbits (1998) J Biomed Mater Res, 42, pp. 357-367; 
Kitsugi, T., Nakamura, T., Oka, M., Senaha, Y., Goto, T., Bonebonding behavior of plasma-sprayed coatings of bioglass, AW-glass ceramic, and tricalcium phosphate on titanium alloy (1996) J Biomed Mater Res, 30, pp. 261-269; 
Kitsugi, T., Yamamuro, T., Nakamura, T., Kotani, S., Kokubo, T., Takeuchi, H., Four calcium phosphate ceramics as bone substitutes for non-weight-bearing (1993) Biomaterials, 14, pp. 216-224; 
De Lauge, G.L., De Putter, C., De Wijs, F.L.J.A., Histological and ultrastructural appearance of the hydroxy apatite-bone interface (1990) J Biomed Mater Res, 24, pp. 829-845; 
Yamada, S., Nakamura, T., Kokubo, T., Oka, M., Yamamuro, T., Degradation of the apatite layer formed on bioactive ceramics and the underlying ceramic surface by osteoclasts in a culture system (1994) Cells and Materials, 4, pp. 347-356; 
Brunski, J.B., Influence of biomechanical factors at the bone-biomaterial interface (1990), pp. 391-405. , Davies JE, editor. The bone-biomaterial interface. Toronto: University of Toronto PressDhert, J.A., Thomsen, P., Blomgren, A.K., Esposito, M., Ericson, L.E., Verbout, A.J., Integration of press-fit implants in cortical bone: A study on interface kInetics (1998) J Biomed Mater Res, 41, pp. 574-583; 
Gao, T.J., Lindholm, T.S., Kommonen, B., Ragni, P., Paronzini, A., Lindholm, T.C., Microscopic evaluation of bone-implant contact beween HA, bioactive glass and tricalcium phosphate implanted in sheep diaphyseal defects (1995) Biomaterials, 16, pp. 1175-1179; 
Oonishi, H., Hench, L.L., Wilson, J., Sugihara, F., Tsuji, E., Kushitani, S., Iwaki, H., Comparative bone growth behavior in granules of bioceramic materials of various sizes (1999) J Biomed Mater Res, 44, pp. 31-43; 
Marie, P.J., De Vernejoul, M.C., Lomri, A., Stimulation of bone formation in osteoporosis patients treated with fluoride associated with increased DNA synthesis by osteoblast cells in vitro (1992) J Bone Miner Res, 7, pp. 103-113; 
Rodan, G.A., Introduction to bone biology (1992) Bone, 13, pp. S3-S6
},
	month = {2001///},
	pages = {463 - 469},
	publisher = {John Wiley \& Sons Inc},
	abstract = {In vitro and in vivo bioactivity studies were performed to assess the biocompatibility of CaO-P                        2O
                        5 glass-reinforced hydroxyapatite (GR-HA) composites. The ability to form an apatite layer by soaking in simulated body fluid (SBF) was examined and surfaces were characterized using FTIR reflection and thin-film X-ray diffraction analyses. Qualitative histology, histomorphometric measurements, and push-out testing were performed in a rabbit model for characterizing bone/implant bonding. Under the in vitro conditions using SBF, an apatite layer could not be formed on GR-HA composites within 8 weeks. Results of push-out testing showed bonding between the composites and bone, ranging from 130-145 N after 2 weeks of implantation. After the longest implantation period, 16 weeks, the GR-HA composite prepared with the higher content of CaO-P
                        2O
                        5 glass showed the highest bonding force, 606 {\textpm} 45 N, compared to 459 {\textpm} 30 N for sintered HA. Development of immature bone and modifications in the turnover of a more mature bone on the surface of GR-HA composites were similar to those on sintered HA. {\textcopyright} 2000 John Wiley \&amp; Sons, Inc.
In vitro and in vivo bioactivity studies were performed to assess the biocompatibility of CaO-P
                        2O
                        5 glass-reinforced hydroxyapatite (GR-HA) composites. The ability to form an apatite layer by soaking in simulated body fluid (SBF) was examined and surfaces were characterized using FTIR reflection and thin-film X-ray diffraction analyses. Qualitative histology, histomorphometric measurements, and push-out testing were performed in a rabbit model for characterizing bone/implant bonding. Under the in vitro conditions using SBF, an apatite layer could not be formed on GR-HA composites within 8 weeks. Results of push-out testing showed bonding between the composites and bone, ranging from 130-145 N after 2 weeks of implantation. After the longest implantation period, 16 weeks, the GR-HA composite prepared with the higher content of CaO-P
                        2O
                        5 glass showed the highest bonding force, 606 {\textpm} 45 N, compared to 459 {\textpm} 30 N for sintered HA. Development of immature bone and modifications in the turnover of a more mature bone on the surface of GR-HA composites were similar to those on sintered HA. {\textcopyright} 2000 John Wiley \&amp; Sons, Inc.
},
	keywords = {animal experiment, animal tissue, Animals, article, Biocompatibility, Body fluids, Bonding, Bone, Bone Substitutes, bone turnover, Ceramic materials, Composite Resins, Durapatite, Fiber reinforced materials, Fourier transform infrared spectroscopy, glass, Glass reinforced hydroxyapatite composites, Glass-reinforced hydroxyapatite composites, Histological studies, histology, Histomorphometric measurements, hydroxyapatite, implant, implantation, Implants (surgical), In vitro bioactivity, In vivo evaluation, Interfaces (materials), male, nonhuman, orthopedic equipment, ossification, Prosthesis Implantation, Push out testing, Push-out testing, rabbit, Rabbits, Spectroscopy, Fourier Transform Infrared, Stress, Mechanical, Surgical equipment, tibia, Time Factors, X ray diffraction, X ray diffraction analysis},
	isbn = {00219304 (ISSN)},
	url = {http://www.scopus.com/inward/record.url?eid=2-s2.0-0035869784\&partnerID=40\&md5=9464ca5ca74972a99d8092171252e0b3},
	author = {Lopes, M.A. and Santos, J.D. and Monteiro, F.J. and Ohtsuki, C. and Osaka, A. and Kaneko, S. and Inoue, H.}
}
